Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The future

H N Wagner1

  • 1Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

Seminars in Nuclear Medicine
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Nuclear medicine offers a molecular perspective on disease, viewing it as a communication disorder. This approach enables personalized diagnostics and treatments by characterizing molecular interactions within the body.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Positron emission tomography of 5-HT transporter sites in the baboon brain with [11C]McN5652.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·1995
Same author

A new era of certainty.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1995
Same author

Intrastriatal dopamine infusion reverses compensatory increases in D2-dopamine receptors in the 6-OHDA lesioned rat.

Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration·1995
Same author

Molecular nuclear medicine: from genotype to phenotype via chemotype.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1995
Same author

In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.

Archives of general psychiatry·1995
Same author

An improved method for the synthesis of radiolabeled McN5652 via thioester precursors.

Nuclear medicine and biology·1995
Same journal

Letter from the Editors.

Seminars in nuclear medicine·2026
Same journal

Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine.

Seminars in nuclear medicine·2026
Same journal

The diagnostic performance and clinical value of [18F]FDG PET/CT in pleural mesothelioma - A systematic review and meta-analysis.

Seminars in nuclear medicine·2026
Same journal

Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies.

Seminars in nuclear medicine·2026
Same journal

<sup>18</sup>F-FDG -PET/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions.

Seminars in nuclear medicine·2026
Same journal

Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.

Seminars in nuclear medicine·2026
See all related articles

Area of Science:

  • Nuclear medicine
  • Molecular biology
  • Genetics

Background:

  • Medicine is shifting towards personalized treatments with certain benefits.
  • Disease is increasingly viewed as a molecular communication disorder, affecting cellular function.
  • Nuclear medicine bridges molecular biology and genetics with clinical practice.

Purpose of the Study:

  • To highlight the potential of nuclear medicine in the future of medical practice and research.
  • To explain how nuclear medicine visualizes molecular processes in vivo.
  • To emphasize the move from anatomical to molecular diagnostics.

Main Methods:

  • Utilizing radioactive tracers to detect photon emissions from molecular interactions.
  • Characterizing transmitters and receptors throughout the human body.

Related Experiment Videos

  • Employing perturbations (stress tests) to identify early signs of abnormal responsiveness.
  • Main Results:

    • Nuclear medicine enables the examination of molecular interactions at picomolar concentrations.
    • Radiotracers can identify changes in gene expression before symptoms manifest.
    • This molecular characterization allows for individualized patient treatment.

    Conclusions:

    • Nuclear medicine's physiological and biochemical approach redefines disease diagnosis.
    • The field is poised to revolutionize healthcare by enabling early, specific molecular diagnoses.
    • Personalized medicine will be driven by in situ molecular characterization.